Related Experiment Video
Updated: Aug 9, 2026
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Localization of cytomegalovirus antigens in liver allografts over time
N D Theise1, M Conn, S N Thung
1Lillian and Henry N. Stratton-Hans Popper Department of Pathology, Mount Sinai Medical Center, New York, NY 10029.
Insights
Immunohistochemical staining for cytomegalovirus (CMV) antigens aids in earlier diagnosis of CMV hepatitis in liver transplant patients. This method detects the virus in biopsy specimens before routine stains, enabling prompt treatment.
Area of Science:
- Hepatology
- Transplantation Immunology
- Virology
Background:
- Cytomegalovirus (CMV) hepatitis is a significant complication following liver transplantation.
- Accurate and timely diagnosis is crucial for effective management.
Purpose of the Study:
- To compare the diagnostic sensitivity of immunoperoxidase staining for CMV antigens against routine hematoxylin-eosin (H&E) staining.
- To evaluate the potential for earlier CMV detection in liver allograft biopsies.
Main Methods:
- Immunoperoxidase staining using monoclonal antibodies for CMV immediate early and early antigens was performed on serial liver biopsy sections.
- Comparison with routine H&E staining in 140 liver allograft recipients.
Main Results:
- CMV hepatitis was confirmed in 11 of 140 patients by H&E stain.
- Immunohistochemistry detected CMV in earlier, H&E-negative biopsies in 7 of 11 patients.
- CMV antigen expression was focal, initially involving sinusoidal cells before hepatocytes, and could persist post-treatment.
Conclusions:
- Immunohistochemical staining allows for earlier detection of CMV infection, potentially leading to more effective treatment.
- Focal nature of CMV infection necessitates thorough examination of biopsy specimens.
- Post-treatment biopsies may offer a more sensitive assessment of ganciclovir therapy efficacy than liver enzyme levels.
Abstract:
Cytomegalovirus (CMV) hepatitis is a common and serious complication of orthotopic liver transplantation. Immunohistochemical studies are the most sensitive methods of diagnosis. We compared immunoperoxidase staining with monoclonal antibodies to CMV immediate early and early antigens with routine hematoxylin-eosin stain. Eleven of 140 liver allograft recipients at our institution had CMV hepatitis identified by hematoxylin-eosin stain on biopsy specimens. We stained serial sections of all previous biopsy specimens and one post-ganciclovir biopsy specimen (when available) from each of these patients. One or both monoclonal antibodies confirmed the original hematoxylin-eosin stain diagnoses. Cytomegalovirus was detected in earlier, hematoxylin-eosin stain-negative biopsy specimens in seven of 11 patients. Detection of immediate early antigen often preceded that of early antigen. Earlier biopsy specimens demonstrated less positive staining, which become more extensive closer in time to the hematoxylin-eosin stain-positive biopsy specimens. Sinusoidal cells became positive earlier than hepatocytes. In one patient occult CMV antigens persisted in biopsy specimens following ganciclovir treatment. We conclude that (1) immunohistochemical staining for CMV antigens can result in earlier detection of viral infection, which may lead to earlier, more effective treatment; (2) CMV infection and antigen expression is focal, requiring extensive examination for diagnosis; (3) extent of occult infection may indicate the extent of active infection in the organ as a whole; (4) most CMV hepatitis begins with infection of sinusoidal lining cells as a result of hematogenous spread from within the allograft or from systemic viremia; and (5) posttreatment biopsy specimens may be more sensitive than resolution of serum liver enzyme abnormalities in evaluating the success of ganciclovir therapy.
